Form 4 for TECH Bio-Techne
Accepted 2025-07-31 00:00:00 ET · period of report 2025-07-29 · accession 0001062993-25-013359 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-31 | 2025-07-29 | TECH | Hippel James | CFO | M - OptEx | $44.33 | +168.6K | 275.2K | +158% | +$7.47M |
| D | 2025-07-31 | 2025-07-29 | TECH | Hippel James | CFO | F - Tax | $58.55 | -147.4K | 127.8K | -54% | -$8.63M |
| D | 2025-07-31 | 2025-07-29 | TECH | Hippel James | CFO | M - OptEx | $0.00 | -168.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-29 | M | A | 168,620 | $44.33 | 275,230 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-29 | F | D | 147,431 | $58.55 | 127,799 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2025-07-29 | M | D | 168,620 | $0.00 | 0 | D | $44.33 · — to 2025-08-08 | 168,620 Common Stock | (F1) Fully exercisable. |